Hungarian pharmaceutical company Gedeon Richter announced on Tuesday the acquisition of the women's health discovery portfolio of US-based biotech company Celmatix. The portfolio includes assets targeting fertility, endometriosis and ovarian ageing. The development of the acquired programmes will be led by Richter's women's health R+D hub in Belgium. Celmatix will receive an upfront payment and […]

Hungarian-owned Biolab Diagnostic Laboratory Plc. is implementing a EUR 3.26 million capacity expansion project at its Pomáz site, the Hungarian Investment Promotion Agency (HIPA) reports. The company manufactures microbiological diagnostic products for the pharmaceutical and medical technology sectors and is the only company in Central Europe to provide laboratories with a complete range of equipment […]

Gedeon Richter Plc. and Hikma Pharmaceuticals Plc. along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc. (“Hikma”) announcee this Monday that the U.S. Food and Drug Administration (FDA) has granted approval for the Biologics License Applications (BLA) of their biosimilar denosumab products, EnobyTM (denosumab-qbde) and XtrenboTM (denosumabqbde), referencing Prolia® and Xgeva®, respectively. Denosumab is […]